Home New Customer? Create Account
Member Login:

Kits for the Detection of Antibodies to EBV Viral Capsid Antigen - VCA

ODZ-084 - anti-VCA EBV IgG (CSF), 96 wells

PRICE

$336.00

Enter Quantity:

Kits for the Detection of Antibodies to EBV Viral Capsid Antigen - VCA

Features

· Complete panel of EBV serological markers can be examined in single dilution of serum sample

· Qualitative screening or quantitative determination

· Validated for serum and cerebrospinal fluid (CSF) samples

· Supplied with software for intrathecal antibody synthesis calculation

· ELISA-VIDITEST anti-VCA IgM contains RF sorbent for elimination of interfering IgG antibodies

· High sensitivity and specificity confirmed in multi-laboratory testing

· IF test available for confirmation of the results

Description

IgG antibodies have anamnestic character and persist in an infected individual for the whole life. Seroconversion can be detected in early acute phase of the primary infection. A significant increase in IgG anti-VCA antibody indicates reinfection or reactivation. Avidity determination enables differentiation between primary and past infection and reactivation. IgM and IgA antibody response is typical for an active infection. High levels of IgM anti-VCA are usually present in acute and convalescent phase of infectious mononucleosis (IM), while in EBV reactivation IgM response is low and often undetectable and IgA response is more pronounced. After recovery, both IgM and IgA may persist for several weeks or months.

Overview on VCA assays

ELISA-VIDITEST 

Order #

Product

Method

Evaluation

No. of tests

Sample

Sensitivity/Specificity

ODZ-084

anti-VCA EBV IgG (CSF)*

ELISA

quant.

96

serum, cerebrospinal fluid

98.1% / 97.1%